Cargando…

Thymic hyperplasia in Graves’ disease

Graves’ disease is an autoimmune thyroid condition characterized by the production of autoantibodies against the thyrotropin receptor. It is known to be associated with autoimmune conditions such as myasthenia gravis, Addison's disease, type 1 diabetes mellitus, and vitiligo. We present a case...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotwal, Narendra, Singh, Yashpal, Menon, Anil, Behera, Vineet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712389/
https://www.ncbi.nlm.nih.gov/pubmed/23869315
http://dx.doi.org/10.4103/2230-8210.111676
_version_ 1782277065991520256
author Kotwal, Narendra
Singh, Yashpal
Menon, Anil
Behera, Vineet
author_facet Kotwal, Narendra
Singh, Yashpal
Menon, Anil
Behera, Vineet
author_sort Kotwal, Narendra
collection PubMed
description Graves’ disease is an autoimmune thyroid condition characterized by the production of autoantibodies against the thyrotropin receptor. It is known to be associated with autoimmune conditions such as myasthenia gravis, Addison's disease, type 1 diabetes mellitus, and vitiligo. We present a case of rare autoimmune association of Graves’ disease with thymic hyperplasia which regressed after treatment with antithyroid drugs. Exact pathophysiology of thymic hyperplasia in Graves’ is not well understood; it is likely to be the result of rather than the cause of Graves’ disease.
format Online
Article
Text
id pubmed-3712389
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-37123892013-07-18 Thymic hyperplasia in Graves’ disease Kotwal, Narendra Singh, Yashpal Menon, Anil Behera, Vineet Indian J Endocrinol Metab Case Report Graves’ disease is an autoimmune thyroid condition characterized by the production of autoantibodies against the thyrotropin receptor. It is known to be associated with autoimmune conditions such as myasthenia gravis, Addison's disease, type 1 diabetes mellitus, and vitiligo. We present a case of rare autoimmune association of Graves’ disease with thymic hyperplasia which regressed after treatment with antithyroid drugs. Exact pathophysiology of thymic hyperplasia in Graves’ is not well understood; it is likely to be the result of rather than the cause of Graves’ disease. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3712389/ /pubmed/23869315 http://dx.doi.org/10.4103/2230-8210.111676 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Kotwal, Narendra
Singh, Yashpal
Menon, Anil
Behera, Vineet
Thymic hyperplasia in Graves’ disease
title Thymic hyperplasia in Graves’ disease
title_full Thymic hyperplasia in Graves’ disease
title_fullStr Thymic hyperplasia in Graves’ disease
title_full_unstemmed Thymic hyperplasia in Graves’ disease
title_short Thymic hyperplasia in Graves’ disease
title_sort thymic hyperplasia in graves’ disease
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712389/
https://www.ncbi.nlm.nih.gov/pubmed/23869315
http://dx.doi.org/10.4103/2230-8210.111676
work_keys_str_mv AT kotwalnarendra thymichyperplasiaingravesdisease
AT singhyashpal thymichyperplasiaingravesdisease
AT menonanil thymichyperplasiaingravesdisease
AT beheravineet thymichyperplasiaingravesdisease